Company intelligence / Profile preview

BrainAurora Medical Technology

Shaoxing, Zhejiang, Chinabioworld.com ↗

Ownership: Private
Employees: ~159
Development stage: Other

Overview

BrainAurora Medical Technology is a leading Chinese developer of digital therapeutics for cognitive impairment. It was the first in China to launch a medical-grade DTx product for this indication. Its platform combines brain science with advanced AI technologies to deliver both assessment and intervention solutions across a range of conditions including dementia, depression, ADHD, post-COVID cognitive issues, and developmental dyslexia. The company has demonstrated strong commercialization with significant revenue growth from its DTx products.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceSoftwareDigital therapeutics (DTx)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on BrainAurora Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BrainAurora Medical Technology.

Explore the full profile